Literature DB >> 20050884

What constitutes a 'good' recovery outcome in post-acute Guillain-Barré syndrome? Results of a nationwide survey of post-acute GBS sufferers in the United Kingdom.

I Davidson1, C Wilson, T Walton, S Brissenden, M Campbell, L McGowan.   

Abstract

BACKGROUND: Eighty percent of people with Guillain-Barré Syndrome (GBS) are said to achieve 'good' outcome. 'Good' outcome has been defined as either of the top two scores (0 = Healthy, 1 = minor symptoms or signs, able to run) on a 7-point ordinal scale called the F-score. This assessment of 'good' outcome appears to be an arbitrary benchmark. This study is the first assessment of the differences in outcome between post-acute GBS sufferers reporting these scores. It attempts to compare the physical and emotional differences between respondents reporting '0' and '1' on the F-Score.
METHODS: A postal survey was administered to respondents through the UK Guillain-Barré Syndrome Support Group's national database and included items relating to general patient data, general mobility, F-Score, Hospital Anxiety and Depression Scale, SF 36 and Fatigue Severity Scale.
RESULTS: One thousand five hundred and thirty-five members were surveyed, and of 884/1535 (58%) questionnaires were returned. Results indicate significant differences between those scoring '0' on the F-Score and those scoring '1' in the post-acute phase in terms of anxiety, depression, physical functioning, fatigue and wheelchair use on discharge.
CONCLUSIONS: Significantly poorer outcomes for those scoring '1' on the F-Score suggest that only those scoring '0' should constitute a 'good' outcome in GBS.

Entities:  

Mesh:

Year:  2009        PMID: 20050884     DOI: 10.1111/j.1468-1331.2009.02906.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

2.  Long-term outcome in patients with Guillain-Barré syndrome requiring mechanical ventilation.

Authors:  J Witsch; N Galldiks; A Bender; R Kollmar; J Bösel; C Hobohm; A Günther; I Schirotzek; K Fuchs; E Jüttler
Journal:  J Neurol       Date:  2013-01-09       Impact factor: 4.849

Review 3.  Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence.

Authors:  Yanjun Liu; Xiangqi Tang
Journal:  Front Psychiatry       Date:  2018-09-25       Impact factor: 4.157

Review 4.  Psychiatric Sequelae of Guillain-Barré Syndrome: Towards a Multidisciplinary Team Approach.

Authors:  Christopher Hillyar; Anjan Nibber
Journal:  Cureus       Date:  2020-02-19

5.  Neuropathic Pain in Guillain-Barre Syndrome: Association with Rehabilitation Outcomes and Quality of Life.

Authors:  Tripti Swami; Meeka Khanna; Anupam Gupta; Navin B Prakash
Journal:  Ann Indian Acad Neurol       Date:  2020-11-07       Impact factor: 1.383

6.  Falls in people post-Guillain-Barré syndrome in the United Kingdom: A national cross-sectional survey of community based adults.

Authors:  Ian Davidson; Zachary J Parker
Journal:  Health Soc Care Community       Date:  2022-01-11

Review 7.  Neuropsychiatric manifestations in inflammatory neuropathies: A systematic review.

Authors:  Yusuf A Rajabally; Stefano Seri; Andrea E Cavanna
Journal:  Muscle Nerve       Date:  2016-05-10       Impact factor: 3.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.